Itching relief drug trial for dialysis patients halted early
Symptom relief
Terminated
This study tested a new drug called LT5001 to see if it is safe and how it works in people on dialysis who suffer from severe itching. The trial was stopped early and included 18 adults aged 20 to 75. The main goal was to check for side effects and measure drug levels in the bloo…
Phase: PHASE1, PHASE2 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC